Cover Image

The Past, the Present and the Future of Teledermatology: A Narrative Review

Nello Tommasino, Matteo Megna, Sara Cacciapuoti, Alessia Villani, Fabrizio Martora, Angelo Ruggiero, Lucia Genco, Luca Potestio Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyCorrespondence: Luca Potestio, Section of Dermatology -...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tommasino N (Author), Megna M (Author), Cacciapuoti S (Author), Villani A (Author), Martora F (Author), Ruggiero A (Author), Genco L (Author), Potestio L (Author)
Format:	Book
Published:	Dove Medical Press, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
by: Ruggiero A, et al.
Published: (2022)

Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
by: Potestio L, et al.
Published: (2024)

Herpes Zoster and COVID-19 Vaccination: A Narrative Review
by: Potestio L, et al.
Published: (2023)

Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study
by: Megna M, et al.
Published: (2024)

L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter]
by: Potestio L, et al.
Published: (2024)

Risk Factors for Psoriasis Flares: A Narrative Review
by: Potestio L, et al.
Published: (2024)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
by: Potestio L, et al.
Published: (2023)

Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
by: Megna M, et al.
Published: (2023)

Teledermatologia: passado, presente e futuro Teledermatology: past, present and future
by: Hélio Amante Miot, et al.
Published: (2005)

Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
by: Martora F, et al.
Published: (2024)

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
by: Potestio L, et al.
Published: (2023)

Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
by: Luca Potestio, et al.
Published: (2024)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
by: Martora F, et al.
Published: (2023)

Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report
by: Martora F, et al.
Published: (2024)

Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study
by: Ruggiero A, et al.
Published: (2023)

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
by: Potestio L, et al.
Published: (2023)

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
by: Martora F, et al.
Published: (2024)

Ultra-Cycling- Past, Present, Future: A Narrative Review
by: Lucas Tiemeier, et al.
Published: (2024)

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature
by: Martora F, et al.
Published: (2022)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
by: Martora F, et al.
Published: (2023)

Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments
by: Battista T, et al.
Published: (2023)

JAK Inhibitors in Psoriatic Disease
by: Megna M, et al.
Published: (2023)

Store-and-Forward Images in Teledermatology: Narrative Literature Review
by: Simon W Jiang, et al.
Published: (2022)

A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab [Corrigendum]
by: Megna M, et al.
Published: (2024)

A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
by: Megna M, et al.
Published: (2023)

The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials
by: Potestio L, et al.
Published: (2024)

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
by: Potestio L, et al.
Published: (2023)

Exploring Current Evidence on the Past, the Present, and the Future of the Heart Team: A Narrative Review
by: Alexandru Burlacu, et al.
Published: (2020)

Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas
by: Cacciapuoti S, et al.
Published: (2023)

The Peer Review Process: Past, Present, and Future
by: John A. Drozdz, et al.
Published: (2024)

The past, present and future of Gutta-percha (literature review)
by: A. V. Blinova, et al.
Published: (2020)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence
by: Ruggiero A, et al.
Published: (2022)

Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study
by: Megna M, et al.
Published: (2022)

Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients’ Assessment
by: Ruggiero A, et al.
Published: (2022)

Past, present and future of the pathophysiological model of the basal ganglia
by: Jose A Obeso, et al.
Published: (2011)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
by: Ruggiero A, et al.
Published: (2022)

Cuba: Its Past, Present, and Future
by: Hall, A. D. (Arthur D.)

Hypertension in Canada: Past, Present, and Future
by: Ernesto L. Schiffrin, et al.
Published: (2016)

Dental Composites: Past, Present and Future
by: Amit Patodiya, et al.
Published: (2012)

Teledermatology Within Correctional Settings in the United States: A Narrative Review of the Literature
by: Samir Kamat, et al.
Published: (2023)